Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Masanori Hayashi

Concepts (97)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Neoplasms
5
2020
194
1.130
Why?
Sarcoma, Ewing
4
2020
55
1.100
Why?
Pituitary Diseases
1
2020
18
0.940
Why?
Histiocytosis, Langerhans-Cell
1
2020
31
0.920
Why?
Neoplasm Recurrence, Local
4
2020
696
0.870
Why?
Pituitary Gland
1
2020
165
0.870
Why?
Proto-Oncogene Proteins B-raf
1
2020
194
0.800
Why?
DNA, Neoplasm
1
2016
169
0.660
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2015
42
0.620
Why?
Thrombocytopenia
1
2015
152
0.550
Why?
Precision Medicine
1
2016
262
0.550
Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
208
0.540
Why?
Anti-Infective Agents
1
2015
207
0.520
Why?
Hydroxyurea
1
2011
32
0.500
Why?
Transfusion Reaction
1
2011
86
0.470
Why?
Biomarkers, Tumor
2
2016
980
0.450
Why?
Perioperative Care
1
2011
195
0.420
Why?
Anemia, Sickle Cell
1
2011
164
0.420
Why?
Sarcoma
3
2020
116
0.390
Why?
Osteosarcoma
3
2020
77
0.390
Why?
Rhabdomyosarcoma
2
2020
36
0.240
Why?
Mice, SCID
3
2016
311
0.240
Why?
Mice, Inbred NOD
3
2016
490
0.230
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
1295
0.220
Why?
Child
8
2020
15345
0.220
Why?
Prognosis
3
2020
3243
0.210
Why?
Polymerase Chain Reaction
1
2020
1158
0.180
Why?
Tumor Cells, Cultured
2
2016
1037
0.180
Why?
Cyclophosphamide
1
2017
237
0.180
Why?
Calmodulin-Binding Proteins
1
2016
20
0.180
Why?
Proto-Oncogene Protein c-fli-1
1
2016
10
0.170
Why?
RNA-Binding Protein EWS
1
2016
8
0.170
Why?
Xenograft Model Antitumor Assays
2
2016
754
0.170
Why?
Translocation, Genetic
1
2016
131
0.170
Why?
Bone Marrow Transplantation
1
2017
286
0.170
Why?
Tumor Stem Cell Assay
1
2015
40
0.170
Why?
Radiotherapy
1
2017
207
0.160
Why?
Pyrazines
1
2015
74
0.150
Why?
Clinical Decision-Making
1
2017
228
0.150
Why?
Wnt Signaling Pathway
1
2015
121
0.150
Why?
Oncogene Proteins, Fusion
1
2016
178
0.150
Why?
Intercellular Signaling Peptides and Proteins
1
2016
369
0.150
Why?
Orthopedic Procedures
1
2017
222
0.140
Why?
Glioblastoma
1
2015
221
0.140
Why?
RNA-Binding Proteins
1
2016
332
0.140
Why?
Tumor Microenvironment
1
2015
284
0.130
Why?
Neoplasm Metastasis
1
2015
603
0.130
Why?
Evidence-Based Medicine
1
2017
719
0.130
Why?
Neoplasm Staging
1
2016
1209
0.130
Why?
Pyridines
1
2015
459
0.120
Why?
Humans
12
2020
102904
0.120
Why?
Flow Cytometry
1
2015
1181
0.110
Why?
Cell Proliferation
2
2016
2295
0.110
Why?
Gene Expression Regulation, Neoplastic
1
2016
1142
0.110
Why?
Mutation
1
2020
3203
0.110
Why?
Algorithms
1
2017
1457
0.110
Why?
Child, Preschool
2
2020
9001
0.100
Why?
Antibodies, Monoclonal
1
2016
1260
0.100
Why?
Clinical Trials as Topic
3
2020
965
0.100
Why?
Brain Neoplasms
1
2015
894
0.100
Why?
Female
5
2020
59243
0.090
Why?
Male
4
2020
58059
0.090
Why?
Adolescent
4
2020
17466
0.080
Why?
Mice
3
2016
14677
0.080
Why?
Disease Models, Animal
1
2015
3739
0.080
Why?
Neoplasms
1
2017
1877
0.080
Why?
Treatment Outcome
2
2017
8589
0.060
Why?
Infant
1
2015
7526
0.060
Why?
Albumins
1
2020
76
0.060
Why?
Animals
3
2016
34111
0.050
Why?
Paclitaxel
1
2020
185
0.050
Why?
Deoxycytidine
1
2020
150
0.050
Why?
Young Adult
3
2020
10111
0.050
Why?
Selection, Genetic
1
2020
297
0.050
Why?
Transplantation, Haploidentical
1
2017
3
0.050
Why?
Retrospective Studies
1
2011
9851
0.040
Why?
Drug Evaluation, Preclinical
1
2016
202
0.040
Why?
Models, Theoretical
1
2020
585
0.040
Why?
Graft Survival
1
2017
399
0.040
Why?
Biological Evolution
1
2020
492
0.040
Why?
Heterografts
1
2015
119
0.040
Why?
Wnt Proteins
1
2016
144
0.040
Why?
Hindlimb
1
2015
130
0.040
Why?
beta Catenin
1
2016
212
0.040
Why?
Combined Modality Therapy
1
2017
1212
0.040
Why?
Amputation
1
2015
174
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
1166
0.030
Why?
Patient Care Team
1
2017
521
0.030
Why?
Adult
3
2020
30098
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2016
561
0.030
Why?
Cell Survival
1
2015
1112
0.030
Why?
Follow-Up Studies
1
2020
4671
0.030
Why?
Immunohistochemistry
1
2015
1871
0.030
Why?
Practice Guidelines as Topic
1
2017
1516
0.020
Why?
Mice, Knockout
1
2015
2766
0.020
Why?
Cell Line, Tumor
1
2015
2789
0.020
Why?
Apoptosis
1
2016
2557
0.020
Why?
Hayashi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)